Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Zidovudine may cause hair loss in advanced-stage HIV patients.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Early diagnosis is crucial for treating alopecia effectively.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

People with alopecia areata often have lower vitamin D levels than healthy people.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

0.05% Betamethasone Dipropionate is the most effective topical treatment for alopecia areata.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

People with alopecia areata often have lower iron levels than healthy people.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Both treatments for alopecia areata showed similar modest effectiveness.